دورية أكاديمية
P51 - Combination of PARP inhibitor olaparib with the vascular disrupting agent NOV202 reduces tumor growth in BRCA1/2 mutated prostate cancer xenografts
| العنوان: | P51 - Combination of PARP inhibitor olaparib with the vascular disrupting agent NOV202 reduces tumor growth in BRCA1/2 mutated prostate cancer xenografts |
|---|---|
| المؤلفون: | Sereti, E., Rehnmark, S., Högberg, M., Bjartell, A. |
| المصدر: | In European Urology Open Science October 2022 44 Supplement 2:S224-S224 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 26661683 |
|---|---|
| DOI: | 10.1016/S2666-1683(22)01984-X |